Hydrolyzed plasminogen polypeptides
A technology of hydrolyzing fiber and lysozyme, which is applied in the field of polypeptide for the treatment of malignant tumors, to achieve the effect of improving survival rate and inhibiting proliferation activity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0015] Activity of Hydrolyzed Plasminogen Polypeptides on Hydrolyzed Plasminogen in Vitro.
[0016] ELISA method was used to detect plasminogen hydrolyzate—angiostatin. With 1ml of 1mg / ml plasmin as substrate, 0.75, 1.5, 3.0 μg of hydrolyzed plasminogen polypeptide (Shanghai Sangong Synthetic) and 6 μg of positive control metalloproteinase were added to the substrate solution respectively. After reacting for 5 minutes at 37°C, centrifuge, take the supernatant, and use the ELISA method to determine the content of angiostatin in the solution. Statins were 14.76, 43.98, 63.98nM respectively.
Embodiment 2
[0018] IC50 of hydrolyzed plasminogen polypeptide on the growth and survival of human vascular endothelial cells cultured in vitro.
[0019] Using MTT colorimetric method. The logarithmic growth of human vascular endothelial cells HUVEC, 1.0 × 10 5 Add it to a 96-well culture plate and culture for 24 hours. Add different concentrations of the experimental drug hydrolyzed plasminogen polypeptide (Shanghai Sangong Synthetic) and the positive control drug paclitaxel to the experimental wells and positive drug control wells; add the same volume of solvent to the blank group. . Set up five duplicate wells per well, culture for 48h, add MTT to each well at 0h, 2h, 8h, 14h, 20h, 24h, 36h, and 48h respectively, add DMSO after 4h of action, incubate for 30min, and incubate at 620nm in a microplate reader Measure the absorbance A value, according to the formula HUVEC growth inhibition rate=(1-absorbance value of the experimental group / absorbance value of the control group)×100%. The ...
Embodiment 3
[0021] In vivo activity of hydrolyzed plasminogen polypeptide was tested in a tumor model.
[0022] Uterine cancer tumor model was established, paclitaxel was used as a positive control drug; the same volume of solvent was added to the blank group, and three doses of polypeptide (Shanghai Sangong Synthetic) were set in the experimental group: 0.75, 1.5, 3 μM / Kg. After 21 days, the number of surviving mice was observed, and the survival rate was calculated. The results showed that the hydrolyzed plasminogen polypeptide can effectively protect mice and improve the survival rate of tumor-bearing mice, with the survival rate reaching 87.5%.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com